Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
Clinical trial NCT06210750 · WITHDRAWN
Trial details
- NCT number
- NCT06210750
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-09
- Primary completion
- 2026-09-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.